Premium
Cytoskeletal toxicity of pectenotoxins in hepatic cells
Author(s) -
Espiña B,
Louzao M C,
Ares I R,
Cagide E,
Vieytes M R,
Vega F V,
Rubiolo J A,
Miles C O,
Suzuki T,
Yasumoto T,
Botana L M
Publication year - 2008
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/bjp.2008.323
Subject(s) - cytoskeleton , clone (java method) , hepatocyte , biology , viability assay , actin , cell culture , microbiology and biotechnology , cell , actin cytoskeleton , cytochalasin d , biochemistry , in vitro , genetics , dna
Background and purpose. Pectenotoxins are macrocyclic lactones found in dinoflagellates of the genus Dinophysis , which induce severe liver damage in mice after i.p. injection. Here, we have looked for the mechanism(s) underlying this hepatotoxicity. Experimental approach. Effects of pectenotoxin (PTX)‐1, PTX‐2, PTX‐2 seco acid (PTX‐2SA) and PTX‐11 were measured in a hepatocyte cell line with cancer cell characteristics (Clone 9) and in primary cultures of rat hepatocytes. Cell morphology was assessed by confocal microscopy; F‐ and G‐actin were selectively stained and cell viability measured by Alamar Blue fluorescence. Key results. Clone 9 cells and primary hepatocytes showed a marked depolymerization of F‐actin with PTX‐1, PTX‐2 and PTX‐11 (1–1000 n M ) associated with an increase in G‐actin level. However, morphology was only clearly altered in Clone 9 cells. PTX‐2SA had no effect on the actin cytoskeleton. Despite the potent F‐actin depolymerizing effect, PTX‐1, PTX‐2 or PTX‐11 did not decrease the viability of Clone 9 cells after 24‐h treatment. Only prolonged incubation (>48 h) with PTXs induced a fall in viability, and under these conditions, morphology of both Clone 9 and primary hepatocytes was drastically changed. Conclusions and implications. Although the actin cytoskeleton was clearly altered by PTX‐1, PTX‐2 and PTX‐11 in the hepatocyte cell line and primary hepatocytes, morphological assessments indicated a higher sensitivity of the cancer‐like cell line to these toxins. However, viability of both cell types was not altered. British Journal of Pharmacology (2008) 155 , 934–944; doi: 10.1038/bjp.2008.323 ; published online 8 September 2008